159 related articles for article (PubMed ID: 37916954)
21. Analytical Validation and Performance Characteristics of Molecular Serum Biomarkers, miR-371a-3p and miR-372-3p, for Male Germ Cell Tumors, in a Clinical Laboratory Setting.
Ye F; Feldman DR; Valentino A; So R; Bromberg M; Khan S; Funt SA; Sheinfeld J; Solit DB; Pessin MS; Peerschke EI
J Mol Diagn; 2022 Aug; 24(8):867-877. PubMed ID: 35934321
[TBL] [Abstract][Full Text] [Related]
22. Detection of recurrences using serum miR-371a-3p during active surveillance in men with stage I testicular germ cell tumours.
Fankhauser CD; Christiansen AJ; Rothermundt C; Cathomas R; Wettstein MS; Grossmann NC; Grogg JB; Templeton AJ; Hirschi-Blickenstorfer A; Lorch A; Gillessen S; Moch H; Beyer J; Hermanns T
Br J Cancer; 2022 May; 126(8):1140-1144. PubMed ID: 34912073
[TBL] [Abstract][Full Text] [Related]
23. Comparative mRNA and microRNA expression profiling of three genitourinary cancers reveals common hallmarks and cancer-specific molecular events.
Li X; Chen J; Hu X; Huang Y; Li Z; Zhou L; Tian Z; Ma H; Wu Z; Chen M; Han Z; Peng Z; Zhao X; Liang C; Wang Y; Sun L; Chen J; Zhao J; Jiang B; Yang H; Gui Y; Cai Z; Zhang X
PLoS One; 2011; 6(7):e22570. PubMed ID: 21799901
[TBL] [Abstract][Full Text] [Related]
24. Clinical utility of plasma miR-371a-3p in germ cell tumors.
Mego M; van Agthoven T; Gronesova P; Chovanec M; Miskovska V; Mardiak J; Looijenga LHJ
J Cell Mol Med; 2019 Feb; 23(2):1128-1136. PubMed ID: 30536846
[TBL] [Abstract][Full Text] [Related]
25. Comprehensive microRNA expression analysis of pediatric gonadal germ cell tumors: unveiling novel biomarkers and signatures.
Santarosa Vieira AG; da Silva LS; Albino da Silva EC; Laus AC; Faria TMV; van Helvoort Lengert A; Martins GE; de Oliveira MA; Reis RM; Lopes LF; Pinto MT
Mol Oncol; 2024 Jun; 18(6):1593-1607. PubMed ID: 38725152
[TBL] [Abstract][Full Text] [Related]
26. miRNAs orchestration of testicular germ cell tumors - Particular emphasis on diagnosis, progression and drug resistance.
Elesawy AE; Abulsoud AI; Moustafa HAM; Elballal MS; Sallam AM; Elazazy O; El-Dakroury WA; Abdel Mageed SS; Abdelmaksoud NM; Midan HM; Shahin RK; Elrebehy MA; Nassar YA; Elazab IM; Elballal AS; Elballal MS; Doghish AS
Pathol Res Pract; 2023 Aug; 248():154612. PubMed ID: 37327566
[TBL] [Abstract][Full Text] [Related]
27. Integrated Microarray-Based Data Analysis of miRNA Expression Profiles: Identification of Novel Biomarkers of Cisplatin-Resistance in Testicular Germ Cell Tumours.
Roška J; Lobo J; Ivovič D; Wachsmannová L; Mueller T; Henrique R; Jerónimo C; Chovanec M; Jurkovičová D
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768818
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of miR-371a-3p to predict viable germ cell tumor in patients with pure seminoma receiving retroperitoneal lymph node dissection.
Konneh B; Lafin JT; Howard J; Gerald T; Amini A; Savelyeva A; Woldu SL; Lewis CM; Jia L; Margulis V; Coleman N; Scarpini C; Frazier AL; Murray MJ; Amatruda JF; Bagrodia A
Andrology; 2023 May; 11(4):634-640. PubMed ID: 36254623
[TBL] [Abstract][Full Text] [Related]
29. MiRNA biomarkers in cancers of the male reproductive system: Are we approaching clinical application?
Constâncio V; Tavares NT; Henrique R; Jerónimo C; Lobo J
Andrology; 2023 May; 11(4):651-667. PubMed ID: 35930290
[TBL] [Abstract][Full Text] [Related]
30. Expression of microRNAs of C19MC in Different Histological Types of Testicular Germ Cell Tumour.
Flor I; Spiekermann M; Löning T; Dieckmann KP; Belge G; Bullerdiek J
Cancer Genomics Proteomics; 2016; 13(4):281-9. PubMed ID: 27365378
[TBL] [Abstract][Full Text] [Related]
31. Serum Levels of MicroRNA miR-371a-3p: A Sensitive and Specific New Biomarker for Germ Cell Tumours.
Dieckmann KP; Radtke A; Spiekermann M; Balks T; Matthies C; Becker P; Ruf C; Oing C; Oechsle K; Bokemeyer C; Hammel J; Melchior S; Wosniok W; Belge G
Eur Urol; 2017 Feb; 71(2):213-220. PubMed ID: 27495845
[TBL] [Abstract][Full Text] [Related]
32. Detection of Recurrence through microRNA-371a-3p Serum Levels in a Follow-up of Stage I Testicular Germ Cell Tumors in the DRKS-00019223 Study.
Belge G; Dumlupinar C; Nestler T; Klemke M; Törzsök P; Trenti E; Pichler R; Loidl W; Che Y; Hiester A; Matthies C; Pichler M; Paffenholz P; Kluth L; Wenzel M; Sommer J; Heinzelbecker J; Schriefer P; Winter A; Zengerling F; Kramer MW; Lengert M; Frey J; Heidenreich A; Wülfing C; Radtke A; Dieckmann KP
Clin Cancer Res; 2024 Jan; 30(2):404-412. PubMed ID: 37967143
[TBL] [Abstract][Full Text] [Related]
33. Report From the International Society of Urological Pathology (ISUP) Consultation Conference on Molecular Pathology of Urogenital Cancers: IV: Current and Future Utilization of Molecular-Genetic Tests for Testicular Germ Cell Tumors.
Looijenga LHJ; Van der Kwast TH; Grignon D; Egevad L; Kristiansen G; Kao CS; Idrees MT
Am J Surg Pathol; 2020 Jul; 44(7):e66-e79. PubMed ID: 32205480
[TBL] [Abstract][Full Text] [Related]
34. Serum Levels of MicroRNA-371a-3p (M371 Test) as a New Biomarker of Testicular Germ Cell Tumors: Results of a Prospective Multicentric Study.
Dieckmann KP; Radtke A; Geczi L; Matthies C; Anheuser P; Eckardt U; Sommer J; Zengerling F; Trenti E; Pichler R; Belz H; Zastrow S; Winter A; Melchior S; Hammel J; Kranz J; Bolten M; Krege S; Haben B; Loidl W; Ruf CG; Heinzelbecker J; Heidenreich A; Cremers JF; Oing C; Hermanns T; Fankhauser CD; Gillessen S; Reichegger H; Cathomas R; Pichler M; Hentrich M; Eredics K; Lorch A; Wülfing C; Peine S; Wosniok W; Bokemeyer C; Belge G
J Clin Oncol; 2019 Jun; 37(16):1412-1423. PubMed ID: 30875280
[TBL] [Abstract][Full Text] [Related]
35. Testicular germ cell tumour cells release microRNA-containing extracellular vesicles that induce phenotypic and genotypic changes in cells of the tumour microenvironment.
Alonso-Crisostomo L; Trendell J; Ferraresso M; Bailey S; Ward D; Scurlock ZGL; Wenlock SC; Bastos CAP; Jugdaohsingh R; Faria NJ; Enright AJ; Scarpini CG; Coleman N; Murray MJ
Int J Cancer; 2024 Jan; 154(2):372-388. PubMed ID: 37632231
[TBL] [Abstract][Full Text] [Related]
36. MicroRNAs miR-371-3 in serum as diagnostic tools in the management of testicular germ cell tumours.
Dieckmann KP; Spiekermann M; Balks T; Flor I; Löning T; Bullerdiek J; Belge G
Br J Cancer; 2012 Nov; 107(10):1754-60. PubMed ID: 23059743
[TBL] [Abstract][Full Text] [Related]
37. Serum miRNA Predicts Viable Disease after Chemotherapy in Patients with Testicular Nonseminoma Germ Cell Tumor.
Leão R; van Agthoven T; Figueiredo A; Jewett MAS; Fadaak K; Sweet J; Ahmad AE; Anson-Cartwright L; Chung P; Hansen A; Warde P; Castelo-Branco P; O'Malley M; Bedard PL; Looijenga LHJ; Hamilton RJ
J Urol; 2018 Jul; 200(1):126-135. PubMed ID: 29474847
[TBL] [Abstract][Full Text] [Related]
38. Epigenetic alterations of testicular germ cell tumours.
Ilijazi D; Shariat SF; Hassler MR; Lemberger U; Ertl IE
Curr Opin Urol; 2020 Mar; 30(2):264-270. PubMed ID: 31905176
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA miR-371a-3p - A Novel Serum Biomarker of Testicular Germ Cell Tumors: Evidence for Specificity from Measurements in Testicular Vein Blood and in Neoplastic Hydrocele Fluid.
Dieckmann KP; Spiekermann M; Balks T; Ikogho R; Anheuser P; Wosniok W; Loening T; Bullerdiek J; Belge G
Urol Int; 2016; 97(1):76-83. PubMed ID: 26989896
[TBL] [Abstract][Full Text] [Related]
40. A stroll through the present and future of testicular germ cell tumour biomarkers.
Tavares NT; Henrique R; Bagrodia A; Jerónimo C; Lobo J
Expert Rev Mol Diagn; 2023 May; 23(5):405-418. PubMed ID: 37088989
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
